Clinical Trial News and Research

RSS
Neurokinin-1 receptor: a potential drug target for the treatment of COVID-19

Neurokinin-1 receptor: a potential drug target for the treatment of COVID-19

Clinical trial reveals optimal period for intensive rehabilitation of arm and hand use after stroke

Clinical trial reveals optimal period for intensive rehabilitation of arm and hand use after stroke

Novel anti-hormonal therapy may be a new treatment option for early-stage breast cancer

Novel anti-hormonal therapy may be a new treatment option for early-stage breast cancer

Pre-emptive intervention during infancy reduces the likelihood of autism diagnosis

Pre-emptive intervention during infancy reduces the likelihood of autism diagnosis

NCTN trials gave 14 million years of additional life to cancer patients, analysis finds

NCTN trials gave 14 million years of additional life to cancer patients, analysis finds

Sunitinib extends progression-free survival in patients with rare neuroendocrine tumor, study shows

Sunitinib extends progression-free survival in patients with rare neuroendocrine tumor, study shows

Study uncovers a new way to counter immune suppression in tumors

Study uncovers a new way to counter immune suppression in tumors

Smartphone-based augmented reality app helps tackle the fear of spiders

Smartphone-based augmented reality app helps tackle the fear of spiders

Ask KHN-Politifact: Is my cloth mask good enough to face the delta variant?

Ask KHN-Politifact: Is my cloth mask good enough to face the delta variant?

EIT Health highlights the urgent need for harnessing data and AI to fight against Alzheimer’s disease

EIT Health highlights the urgent need for harnessing data and AI to fight against Alzheimer’s disease

Many cancer survivors continue to suffer long-term burdensome symptoms, study shows

Many cancer survivors continue to suffer long-term burdensome symptoms, study shows

Immunotherapy treatment may be appropriate for patients with earlier stages of melanoma

Immunotherapy treatment may be appropriate for patients with earlier stages of melanoma

Development of a potential pan-variant aerosol to manage COVID-19

Development of a potential pan-variant aerosol to manage COVID-19

A new synthetic multiantigen MVA vaccine COH04S1 effective against SARS-CoV-2

A new synthetic multiantigen MVA vaccine COH04S1 effective against SARS-CoV-2

A 100% French nasal vaccine against SARS-CoV-2 to move into the clinical phase in 2022

A 100% French nasal vaccine against SARS-CoV-2 to move into the clinical phase in 2022

Thousands of vulnerable hospital patients set to benefit from new COVID-19 treatment

Thousands of vulnerable hospital patients set to benefit from new COVID-19 treatment

mAb treatment can rapidly select for SARS-CoV-2 resistance, suggests study

mAb treatment can rapidly select for SARS-CoV-2 resistance, suggests study

GammaDelta Therapeutics initiates first-in-human phase 1 trial of GDX012 for the treatment of acute myeloid leukemia

GammaDelta Therapeutics initiates first-in-human phase 1 trial of GDX012 for the treatment of acute myeloid leukemia

Multiple sclerosis patients elicit robust T-cell responses to mRNA COVID-19 vaccines

Multiple sclerosis patients elicit robust T-cell responses to mRNA COVID-19 vaccines

Childhood maltreatment causes neurobiological alterations in early stages of life

Childhood maltreatment causes neurobiological alterations in early stages of life